"... on schedule to receive top-line results from the trial in the second half of March 2017 and that soon thereafter it intends to engage potential commercial partners regarding the remaining development and commercialization of trofinetide in the major markets."
Still my favourite line.
- Forums
- ASX - By Stock
- NEU
- Ann: Preliminary Final Report
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.07%
!
$12.96

Ann: Preliminary Final Report, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.96 |
Change
-0.140(1.07%) |
Mkt cap ! $1.612B |
Open | High | Low | Value | Volume |
$13.20 | $13.36 | $12.82 | $4.627M | 354.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7585 | $12.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.03 | 3344 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7585 | 12.960 |
1 | 588 | 12.950 |
2 | 1799 | 12.910 |
2 | 3925 | 12.900 |
3 | 2813 | 12.890 |
Price($) | Vol. | No. |
---|---|---|
13.030 | 3344 | 2 |
13.050 | 1296 | 2 |
13.060 | 1291 | 1 |
13.070 | 2890 | 3 |
13.080 | 3090 | 3 |
Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |